作者: Changrim Lee , Maria C. Edman , Gordon W. Laurie , Sarah F. Hamm-Alvarez , J. Andrew MacKay
DOI: 10.3390/IJMS21176157
关键词:
摘要: Lacripep is a therapeutic peptide derived from the human tear protein, Lacritin. interacts with syndecan-1 and induces mitogenesis upon removal of heparan sulfates (HS) that are attached at extracellular domain syndecan-1. The presence HS prerequisite for clustering stimulates exosome biogenesis release. Therefore, syndecan-1-mediated versus HS-mediated assumed to be mutually exclusive. This study introduces biosynthesized fusion between an elastin-like polypeptide named LP-A96, evaluates its activity on cell motility enhancement biogenesis. LP-A96 activates both downstream pathways in dose-dependent manner. HCE-T cells high confluence treated 1 μM enhanced equipotent Lacripep. However, low density generated 210-fold higher number exosomes compared those As monovalent capable enhancing but not biogenesis, activation by only suggests utility as novel molecular tool Lacritin biology corneal epithelium also implies potential can further improve ocular surface health through induction exosomes.